$EYE

National Vision Holdings, Inc. (EYE): Results of Operations and Financial Condition

National Vision Holdings, Inc. (EYE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 National Vision Holdings, Inc. Reports Second Quarter 2026 Financial Results Strategic Transformation Delivers Accelerated Profitability Raises Full-Year Adjusted Operating Income and Tightens Adjusted Comparable Store Sales Growth Outlook Second quarter 2026 highlig

Original reporting
Published Aug 12, 2026, 10:03 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 10:09 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$EYE
Bullish
high confidence
Mentioned
$EYE
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$EYEBullishHigh
01

Why it matters

The key tradable items are the Q2 profitability improvement (adjusted operating margin expansion) and the updated full-year adjusted operating income and adjusted diluted EPS ranges.

02

Market read

Guidance raise plus margin expansion can prompt earnings estimate upgrades and near-term positioning changes in EYE.

03

What to watch

The release emphasizes managed care and higher-value mix; traders may want to watch whether store growth and marketing spend translate into sustained comparable sales beyond the quarter.

Relevance 7/10Novelty 9/10Timing: filed pre-market today, with updated FY 2026 guidance
alphai · Earnings readEYE · Second quarter 2026 · ended July 4, 2026

Strategic Transformation Delivers Accelerated Profitability Raises Full-Year Adjusted Operating Income and Tightens Adjusted Comparable Store Sales Growth Outlook

Solid quarter

Net revenue increased 2.5% to $498.8 million while Adjusted Operating Income increased 32.7% to $31.6 million, supported by higher average ticket, managed care strength, lower SG&A and a favorable net change in margin on unearned revenue. The company raised its Adjusted Operating Income outlook, although it tightened its Adjusted Comparable Store Sales Growth and net revenue ranges and cited lower self-pay customer traffic.

Revenue
$498.8 million
increased 2.5% y/y
Operating margin · non-GAAP
6.3%
improved 140 basis points y/y
EPS · non-GAAP
$0.25
increased y/y
Fiscal 2026 outlook for the 52 weeks ending January 2, 2027 outlook
$2.037 billion - $2.076 billion

Key metrics

as reported
MetricValueq/qy/y
Net revenueGAAP$498.8 millionincreased 2.5%
Comparable store sales growthother3.4%
Adjusted Comparable Store Sales Growthnon-GAAP2.2%
Store countother1,281 storesgrew 3.3%
Costs applicable to revenueGAAP$208.4 millionincreased 4.0%
Costs applicable to revenue as a percentage of net revenueGAAP41.8%increased 60 basis points
Selling, general and administrative expenses (SG&A)GAAP$243.4 milliondecreased 1.5%
SG&A as a percentage of net revenueGAAP48.8%decreased 200 basis points
Adjusted SG&Anon-GAAP$236.2 milliondecreased 1.6%
Adjusted SG&A as a percentage of net revenuenon-GAAP47.3%a decrease of 200 basis points
Net incomeGAAP$12.4 millionincreased
Net income marginGAAP2.5%improved
Diluted earnings per share (EPS)GAAP$0.15increased
Adjusted Diluted EPSnon-GAAP$0.25increased
Adjusted Operating Incomenon-GAAP$31.6 millionincreased 32.7%
Adjusted Operating Marginnon-GAAP6.3%improved 140 basis points
Year-to-date net revenueGAAP$1,042.7 millionincreased 4.6%
Year-to-date Comparable store sales growthother3.9%
Year-to-date Adjusted Comparable Store Sales Growthnon-GAAP3.4%
Year-to-date net incomeGAAP$43.6 millionincreased
Year-to-date net income marginGAAP4.2%increased
Year-to-date Diluted EPSGAAP$0.54increased
Year-to-date Adjusted Diluted EPSnon-GAAP$0.71increased
Year-to-date Adjusted Operating Incomenon-GAAP$87.0 millionincreased 33.7%
Year-to-date Adjusted Operating Marginnon-GAAP8.3%increased

Fiscal 2026 outlook for the 52 weeks ending January 2, 2027 outlook

  • Revenue$2.037 billion - $2.076 billion
  • Tax rate~30%
  • NoteNew Stores: 30-35
  • NoteAdjusted Comparable Store Sales Growth: 3.0% - 5.0%
  • NoteAdjusted Operating Income: $119 million - $139 million
  • NoteAdjusted Diluted EPS: $0.94 - $1.09
  • NoteDepreciation and Amortization: $92 million - $93 million
  • NoteInterest: $11 million - $13 million
  • NoteCapital Expenditures: $72 million - $76 million
  • NoteAdjusted Diluted EPS assumes approximately 81 million shares.
  • NoteDepreciation and Amortization includes amortization of acquisition intangibles of approximately $0.7 million.
  • NoteInterest is before the impact of gains or losses on change in fair value of derivatives and charges related to debt discounts and deferred financing costs.

Capital returns

  • During the three months ended July 4, 2026, the Company repurchased approximately 1.2 million shares for $20.0 million.
  • As of July 4, 2026, the share repurchase authorization has remaining capacity of $30.0 million.

What drove it

  • Net revenue growth was driven by new store sales, a positive 0.8% impact from the timing of unearned revenue and Adjusted Comparable Store Sales Growth, partially offset by closed stores.
  • Comparable store sales growth reflected higher average ticket and continued strength in the managed care cohort.
  • SG&A declined primarily because of lower associate-related expenses, including variable incentive compensation, and lower advertising expense.
  • The company completed its website replatform, which management described as a unified commerce foundation to connect the exam, prescription and retail journey at scale.
  • Management cited new brand introductions, store segmentation and increased back-half marketing investment as initiatives gaining traction.

Concerns

  • Lower self-pay customer traffic partially offset higher average ticket and continued strength in the managed care cohort.
  • Costs applicable to revenue increased 4.0% to $208.4 million and increased 60 basis points as a percentage of net revenue, reflecting a strategic mix shift toward higher-value product offerings.
  • Higher occupancy expense partially offset lower associate-related expenses and lower advertising expense within SG&A.
  • The company tightened its fiscal 2026 Adjusted Comparable Store Sales Growth outlook to 3.0% - 5.0% from 3.0% - 6.0% and its net revenue outlook to $2.037 billion - $2.076 billion from $2.033 billion - $2.091 billion.
  • The outlook identifies dynamic market conditions, tariffs, transformation-initiative implementation issues, geopolitical issues, higher transportation or other costs due to rising fuel or energy costs, and other macroeconomic risks and uncertainties.

What to watch

  • Whether higher average ticket and managed care cohort strength continue to offset lower self-pay customer traffic.
  • The impact of increased back-half marketing investment on Adjusted Comparable Store Sales Growth.
  • Execution of new brand introductions, store segmentation and the completed website replatform.
  • Delivery against fiscal 2026 Adjusted Operating Income guidance of $119 million - $139 million.
  • Store openings against the fiscal 2026 target of 30-35 new stores.

Balance sheet and cash flow

  • National Vision’s cash balance was $36.0 million as of July 4, 2026.
  • The Company had no borrowings outstanding under its $300.0 million first lien revolving credit facility, exclusive of letters of credit of $6.7 million.
  • Total debt was $237.7 million as of July 4, 2026, consisting of outstanding first lien term loans and finance lease obligations, net of unamortized discounts.

Analysis

National Vision reported a profitable second-quarter improvement despite modest top-line growth. Net revenue increased 2.5% to $498.8 million, while comparable store sales growth was 3.4% and Adjusted Comparable Store Sales Growth was 2.2%. Revenue benefited from new store sales, a positive 0.8% impact from the timing of unearned revenue and comparable-store growth, partly offset by closed stores. Store count ended at 1,281 stores after nine America’s Best openings and two America’s Best closures during the quarter.

The sales mix and customer mix were central to the result. Higher average ticket and continued strength in the managed care cohort supported comparable-store growth, while lower self-pay customer traffic was a counterweight. Management characterized its strategy as an intentional shift toward a healthier customer base and higher-value transactions. The company also said deferred purchases among its least profitable, lower-value transactions were more than offset by these initiatives.

Profitability grew substantially faster than revenue. Adjusted Operating Income increased 32.7% to $31.6 million and Adjusted Operating Margin improved to 6.3% from 4.9%. GAAP net income rose to $12.4 million from $8.7 million, and Diluted EPS increased to $0.15 from $0.11. Lower associate-related expenses and advertising expense reduced SG&A, although higher occupancy expense was a partial offset. Costs applicable to revenue rose 4.0% to $208.4 million and increased 60 basis points to 41.8% of revenue, which the company attributed to the strategic mix shift toward higher-value product offerings. The net change in margin on unearned revenue benefited net income by $2.2 million and Adjusted Operating Income by $2.9 million.

Year-to-date trends also show operating leverage. Net revenue increased 4.6% to $1,042.7 million, while year-to-date Adjusted Operating Income increased 33.7% to $87.0 million and Adjusted Operating Margin increased to 8.3% from 6.5%. The company also repurchased approximately 1.2 million shares for $20.0 million during the quarter, ending with $30.0 million of remaining authorization capacity. Cash was $36.0 million and total debt was $237.7 million as of July 4, 2026.

The fiscal 2026 guide raises the Adjusted Operating Income range to $119 million - $139 million from $107 million - $133 million and raises the lower end of Adjusted Diluted EPS to $0.94 from $0.85 while retaining the $1.09 upper end. At the same time, the company narrowed Adjusted Comparable Store Sales Growth to 3.0% - 5.0% and tightened net revenue to $2.037 billion - $2.076 billion. The key operating questions are whether ticket growth and managed care demand can continue to counter lower self-pay traffic, and whether back-half marketing investment, new brand introductions, store segmentation and the completed website replatform translate into the guided full-year outcome.

Management, verbatim

We delivered stronger profitability as higher-value transactions, managed care customers and ticket growth gained momentum.

Alex Wilkes, National Vision’s CEO

We believe these actions are building a more durable business, and are more than offsetting deferred purchases among our least profitable, lower-value transactions.

Alex Wilkes, National Vision’s CEO

With these initiatives gaining traction, we are raising our adjusted operating income guidance as we continue to drive profitable growth.

Alex Wilkes, National Vision’s CEO

Not in the filing

stated, not guessed
  • GAAP gross profit and gross margin
  • GAAP operating income and operating margin
  • Segment revenue and segment profitability
  • Operating cash flow
  • Free cash flow
  • Cash flow from investing activities
  • Cash flow from financing activities
  • Dividend information
  • Quarter-over-quarter comparisons for reported second-quarter metrics
  • Prior-year values for net revenue, costs applicable to revenue, SG&A, Adjusted SG&A, Adjusted Operating Income and year-to-date Adjusted Operating Income
  • A separately provided previous quarterly-release outlook for formal comparison of actual fiscal 2026 results versus prior guidance
  • CFO commentary

AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

SEC 8-K filed for National Vision’s Q2 2026 results, including non-GAAP metrics and an updated fiscal 2026 outlook.

Company-level read

Ticker impact

$EYEBullishHigh confidence
Context

National Vision reported Q2 results and raised fiscal 2026 adjusted operating income guidance to $119 million to $139 million.

Expected impact

Likely positive bias for the next trading session and subsequent analyst revisions, assuming the raised outlook is viewed as credible.

Evidence & confidence

The filing discloses specific Q2 metrics (revenue, adjusted operating income, margins) and an updated full-year range, which are direct inputs to earnings models.

Market effects

Signals improving profitability and mix shift in the optical retail space, potentially supporting sector multiples for profitable operators.

Limited, company-specific update with no stated regional macro drivers.

Low, US-listed retailer filing with no international policy or supply-chain shock mentioned.

Counterpoint

Raised guidance could still be offset by traffic softness in self-pay cohorts, with profitability partly supported by timing of unearned revenue.

Key entities

  • National Vision Holdings, Inc.

    Optical retailer reporting Q2 2026 financial results and updating FY 2026 guidance.

  • Alex Wilkes

    CEO quoted on profitability drivers and the website replatform milestone.

Every EYE earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$EYEHighAI 8/10

National Vision Holdings (EYE) Q2 2026 Earnings Call Transcript

National Vision Holdings (EYE) reported Q2 2026 net revenue of $498.8M, up 2.5%, with adjusted EPS of $0.25. Adjusted comp sales grew 2.2%, offset by a 4.9% traffic decline due to e-commerce replatforming. The company narrowed its full-year revenue guidance to $2.037B-$2.076B, citing traffic dynamics. Management highlighted a shift toward premium products and cost efficiencies.

$EYEMed

National Vision Holdings, Inc. Q2 2026 Earnings Call Summary

National Vision Holdings, Inc. reported Q2 2026 results and discussed a shift toward higher-value sales. Adjusted Comp Store sales rose 2.2% as average ticket grew 7.1% while customer traffic fell 4.9%, partly due to a e-commerce replatform. Full-year adjusted operating income guidance was raised to $119M-$139M.

$EYEMed

National Vision Raises Outlook as Higher-Value Customers Fuel Breakout Quarter

National Vision Holdings (Nasdaq: EYE) reported Q2 net revenue up 2.5% to $498.8 million and net income of $12.4 million versus $8.7 million. Diluted EPS rose to $0.15 from $0.11, and adjusted operating income increased 32.7% to $31.6 million. The company raised its 2026 adjusted operating income outlook to $119-$139 million from $107-$133 million.

$EYEMedAI 8/10

National Vision Q2 Earnings Call Highlights

National Vision (NASDAQ:EYE) reported positive managed-care comparable sales growth, citing traffic and ticket gains and growth in anti-reflective, transition, polycarbonate and premium progressive lenses. The company said e-commerce replatforming reduced adjusted comparable-store sales by about 150 bps in Q2. Outlook: net revenue $2.03B-$2.08B, adjusted comp sales +3%-5%, adjusted operating income $119M-$139M, adjusted EPS $0.94-$1.09.

$EYEMed

Why is National Vision stock climbing today?

National Vision Holdings shares rose 1.9% in pre-open trading after the company reported Q2 2026 results. Analysts expected about $0.18 EPS on ~$499.84M revenue, versus Q1 adjusted EPS of $0.45 and 6.6% YoY revenue growth. The firm reaffirmed full-year 2026 EPS guidance of $0.85 to $1.09 and filed an 8-K. The earnings call coincided with the U.S. CPI release.